Daiwa Securities Upgrades Merck (MRK) to Outperform (2)

Daiwa Securities analyst Narumi Nakagiri upgraded Merck (NYSE: MRK) from Neutral (3) to Outperform (2) with a price target of $143.00 (from $120.00).

For an analyst ratings summary and ratings history on Merck click here. For more ratings news on Merck click here.

Shares of Merck closed at $130.42 yesterday.

You May Also Be Interested In

• Merck and Daiichi Sankyo withdraw lung cancer drug application
• Infosys Ltd. (INFO:IN) (INFY) PT Lowered to INR1,430 at UBS
• HCL Technologies (HCLT:IN) PT Lowered to INR1,030 at Citi